There was a significant correlation between E - cadherin and alpha - catenin expression, but no correlation was found between p53 expression and E - cadherin or alpha - catenin expression.	"E - cadherin	44	56	Gene_or_gene_product"	"alpha - catenin	61	76	Gene_or_gene_product"	"p53	126	129	Gene_or_gene_product"	"E - cadherin	145	157	Gene_or_gene_product"	"alpha - catenin	161	176	Gene_or_gene_product"	"[{""token"": ""E - cadherin"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - catenin"", ""start_span"": 61, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - catenin"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"
Activation of MybER both prevented the growth arrest induced by interleukin - 6 ( IL - 6) and rapidly restored c - myc expression in nearly terminal differentiated cells that had been exposed to IL - 6 for 3 days.	"MybER	14	19	Gene_or_gene_product"	"interleukin - 6	64	79	Gene_or_gene_product"	"IL - 6	82	88	Gene_or_gene_product"	"c - myc	111	118	Gene_or_gene_product"	"IL - 6	195	201	Gene_or_gene_product"	"[{""token"": ""MybER"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 6"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}]"
Western blot analysis of involved hematologic tissues of the p190 del C transgenics with end - stage disease showed high - level expression of the transgene and tyrosine phosphorylation of Cbl and Hef1 / Cas, proteins previously shown to be affected by Bcr / Abl.	"p190	61	65	Gene_or_gene_product"	"Cbl	189	192	Gene_or_gene_product"	"Hef1	197	201	Gene_or_gene_product"	"Cas	204	207	Gene_or_gene_product"	"Bcr / Abl	253	262	Gene_or_gene_product"	"[{""token"": ""p190"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cbl"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hef1"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cas"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcr / Abl"", ""start_span"": 253, ""end_span"": 262, ""type"": ""Gene_or_gene_product""}]"
Moreover, expression of a dominant negative AP - 2 protein, AP - 2delta ( deleted residues 31 - 117), not only repressed the ErbB - 3 promoter activity but also suppressed endogenous ErbB - 3 transcription in the ErbB - 3 overexpressing cell line MRC - 5VA.	"AP - 2	44	50	Gene_or_gene_product"	"AP - 2delta	60	71	Gene_or_gene_product"	"ErbB - 3	125	133	Gene_or_gene_product"	"ErbB - 3	183	191	Gene_or_gene_product"	"ErbB - 3	213	221	Gene_or_gene_product"	"[{""token"": ""AP - 2"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2delta"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}]"
Complexes containing VEGF165, NRP1, and KDR were also formed in an intercellular fashion by co - culture of EC expressing KDR only, with cells expressing NRP1 only, for example, breast carcinoma cells.	"VEGF165	21	28	Gene_or_gene_product"	"NRP1	30	34	Gene_or_gene_product"	"KDR	40	43	Gene_or_gene_product"	"KDR	122	125	Gene_or_gene_product"	"NRP1	154	158	Gene_or_gene_product"	"[{""token"": ""VEGF165"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"
Our results suggest that formation of a ternary complex of VEGF165, KDR, and NRP1 potentiates VEGF165 binding to KDR.	"VEGF165	59	66	Gene_or_gene_product"	"KDR	68	71	Gene_or_gene_product"	"NRP1	77	81	Gene_or_gene_product"	"VEGF165	94	101	Gene_or_gene_product"	"KDR	113	116	Gene_or_gene_product"	"[{""token"": ""VEGF165"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""NRP1"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}]"
Notably, three immortalizing E6 mutants that do not induce direct p53 degradation but do interact with hADA3 induced the abrogation of p53 - mediated transactivation and G ( 1) cell cycle arrest after DNA damage, comparable to wild - type E6.	"E6	29	31	Gene_or_gene_product"	"p53	66	69	Gene_or_gene_product"	"hADA3	103	108	Gene_or_gene_product"	"p53	135	138	Gene_or_gene_product"	"E6	239	241	Gene_or_gene_product"	"[{""token"": ""E6"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""hADA3"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 239, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"
In contrast, caspase - 3, Fas ligand, Fas / CD95, and PAI showed an inverse correlation to lymph node involvement.	"caspase - 3	13	24	Gene_or_gene_product"	"Fas ligand	26	36	Gene_or_gene_product"	"Fas	38	41	Gene_or_gene_product"	"CD95	44	48	Gene_or_gene_product"	"PAI	54	57	Gene_or_gene_product"	"[{""token"": ""caspase - 3"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD95"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}]"
FGF2 - stimulated microvessel formation was inhibited by sequestration of FGF2 via addition of soluble FGF receptor ( FGFR) chimera protein or anti - FGF2 antibodies.	"FGF2	0	4	Gene_or_gene_product"	"FGF2	74	78	Gene_or_gene_product"	"FGF receptor	103	115	Gene_or_gene_product"	"FGFR	118	122	Gene_or_gene_product"	"FGF2	150	154	Gene_or_gene_product"	"[{""token"": ""FGF2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF2"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF receptor"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFR"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF2"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"
The tumour suppressor p53 and interferon - alpha and - beta ( IFN - alpha / beta) are essential for the induction of apoptosis in cancerous cells and in antiviral immune responses, respectively, but little is known about their interrelationship.	"p53	22	25	Gene_or_gene_product"	"interferon - alpha	30	48	Gene_or_gene_product"	"- beta	53	59	Gene_or_gene_product"	"IFN - alpha	62	73	Gene_or_gene_product"	"beta	76	80	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""interferon - alpha"", ""start_span"": 30, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""- beta"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - alpha"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}]"
BX471 ( R - N - [ 5 - chloro - 2 - [ 2 - [ 4 ( 4 - fluorophenyl) methyl] - 2 - methyl - 1 - piperazinyl] - 2 - oxoethoxy] phenyl] urea hydrochloric acid salt), a CCR1 antagonist, inhibits angiogenic properties of CCL16, whereas blocking of CCR8 or desensitizing CCR2, which are both well known receptors for CCL16, did not abolish endothelial activation.	"CCR1	162	166	Gene_or_gene_product"	"CCL16	213	218	Gene_or_gene_product"	"CCR8	240	244	Gene_or_gene_product"	"CCR2	262	266	Gene_or_gene_product"	"CCL16	308	313	Gene_or_gene_product"	"[{""token"": ""CCR1"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCL16"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCR8"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCR2"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""CCL16"", ""start_span"": 308, ""end_span"": 313, ""type"": ""Gene_or_gene_product""}]"
Inhibition of the autocrine angiotensin system with the converting - enzyme inhibitor or the receptor antagonist also leads to increased expression of the proto - oncogene c - src: pp60c - src mRNA increased 7 - 11 - fold, c - src protein 3 - fold, and c - src kinase activity 2 - 3 - fold.	"angiotensin	28	39	Gene_or_gene_product"	"c - src	172	179	Gene_or_gene_product"	"pp60c - src	181	192	Gene_or_gene_product"	"c - src	223	230	Gene_or_gene_product"	"c - src	253	260	Gene_or_gene_product"	"[{""token"": ""angiotensin"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp60c - src"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - src"", ""start_span"": 253, ""end_span"": 260, ""type"": ""Gene_or_gene_product""}]"
Analysis of gene expression revealed increased expression of ANGPT1, ANGPT2, platelet - derived growth factor - B, placental growth factor, and VEGF mRNA in AdCA5 - injected eyes.	"ANGPT1	61	67	Gene_or_gene_product"	"ANGPT2	69	75	Gene_or_gene_product"	"platelet - derived growth factor - B	77	113	Gene_or_gene_product"	"placental growth factor	115	138	Gene_or_gene_product"	"VEGF	144	148	Gene_or_gene_product"	"[{""token"": ""ANGPT1"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANGPT2"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelet - derived growth factor - B"", ""start_span"": 77, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""placental growth factor"", ""start_span"": 115, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}]"
In the present study, we applied the alginate implant angiogenesis model in mice with normal ANG II levels, elevated ANG II levels by transgenic overexpression of angiotensinogen ( AOGEN), or in AT2 receptor - deficient mice.	"ANG II	93	99	Gene_or_gene_product"	"ANG II	117	123	Gene_or_gene_product"	"angiotensinogen	163	178	Gene_or_gene_product"	"AOGEN	181	186	Gene_or_gene_product"	"AT2 receptor	195	207	Gene_or_gene_product"	"[{""token"": ""ANG II"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANG II"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensinogen"", ""start_span"": 163, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""AOGEN"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""AT2 receptor"", ""start_span"": 195, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}]"
From these results, it was suggested that PPARgamma activation might suppress COX - 2 expression via the nuclear factor - kappaB pathway in the ovarian carcinoma cells and that low expression of PPARgamma and high expression of COX - 2 might be involved in carcinogenesis and progression of ovarian tumours.	"PPARgamma	42	51	Gene_or_gene_product"	"COX - 2	78	85	Gene_or_gene_product"	"nuclear factor - kappaB	105	128	Gene_or_gene_product"	"PPARgamma	195	204	Gene_or_gene_product"	"COX - 2	228	235	Gene_or_gene_product"	"[{""token"": ""PPARgamma"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 105, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""COX - 2"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene_or_gene_product""}]"
We also show that VEGFR1 + cells express VLA - 4 ( also known as integrin alpha4beta1), and that tumour - specific growth factors upregulate fibronectin - - a VLA - 4 ligand - - in resident fibroblasts, providing a permissive niche for incoming tumour cells.	"VEGFR1	18	24	Gene_or_gene_product"	"VLA - 4	41	48	Gene_or_gene_product"	"integrin alpha4beta1	65	85	Gene_or_gene_product"	"fibronectin	141	152	Gene_or_gene_product"	"VLA - 4	159	166	Gene_or_gene_product"	"[{""token"": ""VEGFR1"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""VLA - 4"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin alpha4beta1"", ""start_span"": 65, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""VLA - 4"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"
Disruption of Mitf blocked HGF - dependent increases in endogenous c - Met message and protein levels, indicating that HGF regulates its own receptor levels via Mitf.	"Mitf	14	18	Gene_or_gene_product"	"HGF	27	30	Gene_or_gene_product"	"c - Met	67	74	Gene_or_gene_product"	"HGF	119	122	Gene_or_gene_product"	"Mitf	161	165	Gene_or_gene_product"	"[{""token"": ""Mitf"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Met"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mitf"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}]"
Because PIM - 1 is a STAT5 target gene, we analyzed the role of the family of PIM serine / threonine kinases ( PIM - 1 to PIM - 3) in PTK - mediated transformation of hematopoietic cells.	"PIM - 1	8	15	Gene_or_gene_product"	"STAT5	21	26	Gene_or_gene_product"	"PIM - 1	111	118	Gene_or_gene_product"	"PIM - 3	122	129	Gene_or_gene_product"	"PTK	134	137	Gene_or_gene_product"	"[{""token"": ""PIM - 1"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT5"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 1"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 3"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTK"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
However, we demonstrate a novel and more complex role for PSMA in angiogenesis, where it is a principal component of a regulatory loop that is tightly modulating laminin - specific integrin signaling and GTPase - dependent, p21 - activated kinase 1 ( PAK - 1) activity.	"PSMA	58	62	Gene_or_gene_product"	"laminin	162	169	Gene_or_gene_product"	"integrin	181	189	Gene_or_gene_product"	"p21 - activated kinase 1	224	248	Gene_or_gene_product"	"PAK - 1	251	258	Gene_or_gene_product"	"[{""token"": ""PSMA"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""laminin"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21 - activated kinase 1"", ""start_span"": 224, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAK - 1"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}]"
This negative regulation is mediated by the cytoskeleton as the disruption of interactions between the PSMA cytoplasmic tail and the anchor protein filamin A decreases PSMA activity, integrin function, and PAK activation.	"PSMA	103	107	Gene_or_gene_product"	"filamin A	148	157	Gene_or_gene_product"	"PSMA	168	172	Gene_or_gene_product"	"integrin	183	191	Gene_or_gene_product"	"PAK	206	209	Gene_or_gene_product"	"[{""token"": ""PSMA"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""filamin A"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAK"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
These data imply that PSMA participates in an autoregulatory loop, wherein active PSMA facilitates integrin signaling and PAK activation, leading to both productive invasion and downregulation of integrin beta ( 1) signaling via reduced PSMA activity.	"PSMA	22	26	Gene_or_gene_product"	"PSMA	82	86	Gene_or_gene_product"	"integrin	99	107	Gene_or_gene_product"	"PAK	122	125	Gene_or_gene_product"	"PSMA	237	241	Gene_or_gene_product"	"[{""token"": ""PSMA"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAK"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Gene_or_gene_product""}]"
Female double Smad1 Smad5 and triple Smad1 Smad5 Smad8 conditional knockout mice become infertile and develop metastatic granulosa cell tumors.	"Smad1	14	19	Gene_or_gene_product"	"Smad5	20	25	Gene_or_gene_product"	"Smad1	37	42	Gene_or_gene_product"	"Smad5	43	48	Gene_or_gene_product"	"Smad8	49	54	Gene_or_gene_product"	"[{""token"": ""Smad1"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad1"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad8"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}]"
Interestingly, CDK4 - expressing cells, but not CDK2 - expressing cells, strongly synergize with lack of p27 ( Kip1) to generate pituitary carcinomas that appear with shortened latency and are drastically more aggressive than those arising in p27 ( - / -) mice.	"CDK4	15	19	Gene_or_gene_product"	"CDK2	48	52	Gene_or_gene_product"	"p27	105	108	Gene_or_gene_product"	"Kip1	111	115	Gene_or_gene_product"	"p27	243	246	Gene_or_gene_product"	"[{""token"": ""CDK4"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kip1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27"", ""start_span"": 243, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"
Immunohistochemistry examinations in the human surgical specimens have shown that a downregulation of TSP - 1 during the progression of cervical carcinogenesis was accompanied by an emergence in the upregulation of stroma markers, alpha - smooth muscle actin ( alpha - SMA) and desmin.	"TSP - 1	102	109	Gene_or_gene_product"	"stroma markers	215	229	Gene_or_gene_product"	"alpha - smooth muscle actin	231	258	Gene_or_gene_product"	"alpha - SMA	261	272	Gene_or_gene_product"	"desmin	278	284	Gene_or_gene_product"	"[{""token"": ""TSP - 1"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""stroma markers"", ""start_span"": 215, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - smooth muscle actin"", ""start_span"": 231, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - SMA"", ""start_span"": 261, ""end_span"": 272, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 278, ""end_span"": 284, ""type"": ""Gene_or_gene_product""}]"
Transfection with TSP - 1 and purified TSP - 1 added to NIH3T3 cells did not alter the protein levels of alpha - SMA and desmin but significantly inhibited matrix metalloprotease - 2 activity.	"TSP - 1	18	25	Gene_or_gene_product"	"TSP - 1	39	46	Gene_or_gene_product"	"alpha - SMA	105	116	Gene_or_gene_product"	"desmin	121	127	Gene_or_gene_product"	"matrix metalloprotease - 2	156	182	Gene_or_gene_product"	"[{""token"": ""TSP - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - SMA"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloprotease - 2"", ""start_span"": 156, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"
Akt knockdown and an mTOR inhibitor revealed the importance of the Akt / mTOR pathway in the postirradiation accumulation of HIF - 1alpha.	"Akt	0	3	Gene_or_gene_product"	"mTOR	21	25	Gene_or_gene_product"	"Akt	67	70	Gene_or_gene_product"	"mTOR	73	77	Gene_or_gene_product"	"HIF - 1alpha	125	137	Gene_or_gene_product"	"[{""token"": ""Akt"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Based on the observation that netrin - 1, the anti - apoptotic ligand for the dependence receptors DCC and UNC5H is up - regulated in colonic crypts in response to NF - kappaB, we show here that colorectal cancers from inflammatory bowel diseases patients have selected up - regulation of netrin - 1.	"netrin - 1	30	40	Gene_or_gene_product"	"DCC	99	102	Gene_or_gene_product"	"UNC5H	107	112	Gene_or_gene_product"	"NF - kappaB	164	175	Gene_or_gene_product"	"netrin - 1	289	299	Gene_or_gene_product"	"[{""token"": ""netrin - 1"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCC"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""UNC5H"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""netrin - 1"", ""start_span"": 289, ""end_span"": 299, ""type"": ""Gene_or_gene_product""}]"
ICAM - 3 enhances the migratory and invasive potential of human non - small cell lung cancer cells by inducing MMP - 2 and MMP - 9 via Akt and CREB.	"ICAM - 3	0	8	Gene_or_gene_product"	"MMP - 2	111	118	Gene_or_gene_product"	"MMP - 9	123	130	Gene_or_gene_product"	"Akt	135	138	Gene_or_gene_product"	"CREB	143	147	Gene_or_gene_product"	"[{""token"": ""ICAM - 3"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""CREB"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
METHODS: Using human colon adenocarcinoma tissues ( hereinafter referred to as colon cancer) and their corresponding non - diseased colon from 114 patients ' biopsies, the expression of SPARC and vascular endothelial growth factor ( VEGF) were investigated by immunohistochemistry staining to assessment the relationship between SPARC and VEGF, as well as their prognostic significance in patients.	"SPARC	186	191	Gene_or_gene_product"	"vascular endothelial growth factor	196	230	Gene_or_gene_product"	"VEGF	233	237	Gene_or_gene_product"	"SPARC	329	334	Gene_or_gene_product"	"VEGF	339	343	Gene_or_gene_product"	"[{""token"": ""SPARC"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 196, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 329, ""end_span"": 334, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 339, ""end_span"": 343, ""type"": ""Gene_or_gene_product""}]"
This induction was due to activation of autophagic flux, as there was further increase in LC3 - II expression upon treatment with lysosomal inhibitors, clear decline of the autophagy substrate p62, and an mRFP - GFP - LC3 fluorescence change in sorafenib - treated hepatoma cells.	"LC3 - II	90	98	Gene_or_gene_product"	"p62	193	196	Gene_or_gene_product"	"mRFP	205	209	Gene_or_gene_product"	"GFP	212	215	Gene_or_gene_product"	"LC3	218	221	Gene_or_gene_product"	"[{""token"": ""LC3 - II"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""p62"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""mRFP"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""GFP"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""LC3"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}]"
Here we found that inactivation of the Notch effectors Hes1, Hes3 and Hes5, but not Hes1 alone, led to reduced cell proliferation, increased secretory cell formation and altered intestinal structures in adult mice.	"Notch	39	44	Gene_or_gene_product"	"Hes1	55	59	Gene_or_gene_product"	"Hes3	61	65	Gene_or_gene_product"	"Hes5	70	74	Gene_or_gene_product"	"Hes1	84	88	Gene_or_gene_product"	"[{""token"": ""Notch"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes3"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes5"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hes1"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}]"
Coexpression of the human Met receptor and its ligand, hepatocyte growth factor / scatter factor ( HGF / SF), in NIH 3T3 fibroblasts causes the cells to become tumorigenic in nude mice.	"Met	26	29	Gene_or_gene_product"	"hepatocyte growth factor	55	79	Gene_or_gene_product"	"scatter factor	82	96	Gene_or_gene_product"	"HGF	99	102	Gene_or_gene_product"	"SF	105	107	Gene_or_gene_product"	"[{""token"": ""Met"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""hepatocyte growth factor"", ""start_span"": 55, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""scatter factor"", ""start_span"": 82, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""SF"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"
Little difference was observed in their transforming efficiency ( 0. 2 - 0. 3 transformants / micrograms DNA) between the combinations of oncogenes applied but a tendency was noted that cells transfected with ras or src in combination with myc developed the capacity to grow for a longer period and differentiated at a later stage than those transfected solely with ras or src.	"ras	209	212	Gene_or_gene_product"	"src	216	219	Gene_or_gene_product"	"myc	240	243	Gene_or_gene_product"	"ras	366	369	Gene_or_gene_product"	"src	373	376	Gene_or_gene_product"	"[{""token"": ""ras"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""src"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""myc"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 366, ""end_span"": 369, ""type"": ""Gene_or_gene_product""}, {""token"": ""src"", ""start_span"": 373, ""end_span"": 376, ""type"": ""Gene_or_gene_product""}]"
Treatment with anti - Fas, however, significantly decreased Fas - c - erbB2 and Fas - c - met association.	"Fas	22	25	Gene_or_gene_product"	"Fas	60	63	Gene_or_gene_product"	"c - erbB2	66	75	Gene_or_gene_product"	"Fas	80	83	Gene_or_gene_product"	"c - met	86	93	Gene_or_gene_product"	"[{""token"": ""Fas"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB2"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - met"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}]"
GM - CSF or IL - 2 vaccines or gammaIFN decreased tumor nodules significantly ( GM - CSF 13 + / - 4, IL - 2 14 + / - 6 vs. control 75 + / - 24, P < 0. 001).	"GM - CSF	0	8	Gene_or_gene_product"	"IL - 2	12	18	Gene_or_gene_product"	"gammaIFN	31	39	Gene_or_gene_product"	"GM - CSF	80	88	Gene_or_gene_product"	"IL - 2	101	107	Gene_or_gene_product"	"[{""token"": ""GM - CSF"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""gammaIFN"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""GM - CSF"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"
